Treatment for paediatric chronic fatigue syndrome or myalgic encephalomyelitis (CFS/ME) and comorbid depression: a systematic review.
Loades, Maria E, Sheils, Elizabeth A, Crawley, Esther · BMJ open · 2016 · DOI
Quick Summary
This review looked at studies treating depression in children and teens with ME/CFS, since about one-third of young people with ME/CFS also experience depression. The researchers found that while some treatments like cognitive-behavioural therapy and specialized hospital programmes showed some promise in helping with depression symptoms, there are no studies specifically designed to test what works best for depression in young people with ME/CFS. This means we still don't have clear answers about the best way to help these young people.
Why It Matters
This systematic review highlights a critical gap in paediatric ME/CFS care: the lack of evidence-based treatment approaches for the substantial proportion of young people experiencing comorbid depression. Understanding how to effectively treat depression in this population is essential for improving quality of life and treatment outcomes, as depression may complicate ME/CFS recovery and vice versa.
Observed Findings
At least 30% of young people with CFS/ME experience depressive symptoms
No published studies specifically tested depression treatment in paediatric CFS/ME
Young people with significant depression have been systematically excluded from most ME/CFS treatment trials
Cognitive-behavioural therapy for CFS/ME and multicomponent inpatient programmes showed some promise in reducing depressive symptoms
One small retrospective antiviral study suggested possible benefit
Inferred Conclusions
There is currently no consistent or evidence-based treatment approach for depression comorbid with paediatric ME/CFS
Depressed young people are underrepresented in ME/CFS treatment research, limiting our ability to understand how depression affects treatment outcomes
Future research must specifically design trials to test depression interventions in paediatric CFS/ME populations
Remaining Questions
Which specific psychological or pharmacological interventions are most effective for treating depression in children and adolescents with ME/CFS?
Does comorbid depression mediate or predict outcomes of ME/CFS treatments, and should treatment approaches differ for depressed versus non-depressed patients?
What This Study Does Not Prove
This review does not establish which specific treatments are most effective for depression in paediatric ME/CFS, nor does it prove whether depression causes worse ME/CFS outcomes or merely reflects disease burden. The absence of dedicated studies means we cannot determine whether depression requires specialized treatment approaches in this population or whether standard depression treatments are appropriate.
Tags
Symptom:Fatigue
Phenotype:Pediatric
Method Flag:Weak Case DefinitionSmall SampleExploratory OnlyMixed Cohort
Why have depressed young people been excluded from ME/CFS trials, and what are the implications of this exclusion?
Do standard depression treatments need modification when delivered to young people with ME/CFS, given potential energy limitations and post-exertional malaise?